Skip to main content
. 2021 Dec 1;13(1):107–116. doi: 10.1111/1759-7714.14232

TABLE 2.

Characteristics of CNS metastases during treatment with crizotinib (n = 10)

Local treatment before crizotinib n = 1
Uncontrolled CNS lesions before crizotinib n = 10
Symptoms related to CNS metastases before crizotinib n = 1
Measurable intracranial lesions n = 5
Radiological evaluation in CNS during treatment with crizotinib n = 9